Valbiotis SA (FR:ALVAL) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Valbiotis, a French firm specializing in health nutrition products to combat metabolic disorders, reported its voting rights and share capital structure as of July 31, 2024, listing 15,794,596 shares and over 16 million voting rights. The company, noted for its innovative approach utilizing both terrestrial and marine plants, aims to reduce cardiovascular risks through its product line. It maintains a robust research presence in France and a subsidiary in Canada, supported by European Union funds and recognized by BPI France.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.